Answers are grounded in this paper and cite their sources.
SCA is associated with alterations in markers of oxidative stress including an increased MDA level, decreased antioxidant enzyme levels, and altered levels of enzyme cofactors (zinc, copper, and iron). This suggests that these antioxidant enzymes could be used as effective therapeutic targets for the treatment of this disease and supplementation of patients with substances with antioxidant properties may reduce the complications of this disease.
No takes yet. Share an insight, caveat, or question.
Al-Naama et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: